Resultados da busca - Javier Ampuero
- Mostrando 1 - 20 resultados de 30
- Ir para a próxima página
-
1
-
2
Wilson's disease: Revisiting an old friend por Ana Lucena-Valera, Domingo Perez-Palacios, Rocío Múñoz‐Hernández, Manuel Romero‐Gómez, Javier Ampuero
Publicado em 2021Revisão -
3
miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis por Chang‐Hai Liu, Javier Ampuero, Antonio Gil‐Gómez, Rocío Montero‐Vallejo, Ángela Rojas, Rocío Múñoz‐Hernández, Rocío Gallego‐Durán, Manuel Romero‐Gómez
Publicado em 2018Revisão -
4
Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction–Associated Steatotic Liver Disease in Lean Individuals por Samuel J. Martínez‐Domínguez, Sandra G. García, Carla J. Gargallo-Puyuelo, Beatriz Gallego-Llera, Pilar Callau, Carolina Mendi, M Arroyo, Miguel Ángel Simón-Marco, Javier Ampuero, Fernando Gomollón
Publicado em 2023Artigo -
5
Metformin Inhibits Glutaminase Activity and Protects against Hepatic Encephalopathy por Javier Ampuero, Isidora Ranchal, David Brandariz-Núñez, María del Mar Díaz-Herrero, M. Maraver, José Antonio Del Barrio del Campo, Ángela Rojas, Inés Camacho, Blanca Figueruela, Juan Bautista, Manuel Romero‐Gómez
Publicado em 2012Artigo -
6
Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis por Astrid Ruiz‐Margáin, Ricardo Ulises Macías‐Rodríguez, Javier Ampuero, Francisco Javier Cubero, Luis Alberto Chi‐Cervera, Silvia L. Ríos-Torres, Andrés Duarte‐Rojo, Ángeles Espinosa-Cuevas, Manuel Romero‐Gómez, Aldo Torre
Publicado em 2016Artigo -
7
Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy por J.A. Del Campo, M. García‐Valdecasas, Antonio Gil‐Gómez, Ángela Rojas, Paloma Gallego, Javier Ampuero, Rocío Gallego‐Durán, Helena Pastor, Lourdes Grande, Javier Padillo-Ruíz, Jordi Muntané, Manuel Romero‐Gómez
Publicado em 2018Artigo -
8
The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease por Antonio Olveira, Salvador Augustín, Salvador Benlloch, Javier Ampuero, Jorge Alonso Suárez‐Pérez, Susana Armesto, Eva Vilarrasa, I. Belinchón, Pedro Herranz, Javier Crespo, Francisco Guimerá, Lara Gómez-Labrador, Victor Martín, J.M. Carrascosa
Publicado em 2023Revisão -
9
Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events por Jérôme Boursier, Hannes Hagström, Mattias Ekstedt, C Moreau, Martín Bonacci, S. Cure, Javier Ampuero, Patrik Nasr, Lilian Tallab, Clémence M. Canivet, Stergios Kechagias, Yolanda Sánchez, Eloise Dincuff, Ana Lucena, Marine Roux, Jérémie Riou, Aldo Trylesinski, Manuel Romero‐Gómez
Publicado em 2022Artigo -
10
Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis por María Pilar Ballester, Thomas H. Tranah, Lorenz Balcar, Alessandra Fiorillo, Javier Ampuero, Annarein Kerbert, Karen Louise Thomsen, María Desamparados Escudero, Mattias Mandorfer, Thomas Reiberger, Debbie L. Shawcross, Manuel Romero‐Gómez, Carmina Montoliú, Juan Antonio Carbonell-Asíns, Rajiv Jalan
Publicado em 2023Artigo -
11
Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis por Thomas H. Tranah, María Pilar Ballester, Juan Antonio Carbonell-Asíns, Javier Ampuero, Gonçalo Alexandrino, Andra Caracostea, Yolanda Sánchez‐Torrijos, Karen Louise Thomsen, Annarein Kerbert, María Capilla, Manuel Romero‐Gómez, Desamparados Escudero‐García, Carmina Montoliú, Rajiv Jalan, Debbie L. Shawcross
Publicado em 2022Artigo -
12
An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography por Jiaxu Liang, Javier Ampuero, Hao Niu, Kento Imajo, Mazen Noureddin, Jaideep Behari, Dae Ho Lee, Richard L. Ehman, Fredrik Rorsman, Johan Vessby, Juan Ramón Lacalle-Remigio, Ferenc Mózes, Michael Pavlides, Quentin M. Anstee, Stephen A. Harrison, Javier Castell, Rohit Loomba, Manuel Romero‐Gómez
Publicado em 2023Revisão -
13
Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Diseas... por Salvatore Petta, Giada Sebastiani, Mauro Viganò, Javier Ampuero, Vincent Wai‐Sun Wong, Jérôme Boursier, Annalisa Berzigotti, Elisabetta Bugianesi, Anna Ludovica Fracanzani, Calogero Cammà, Marco Enea, Marraud des Grottes, V. Di Marco, Ramy Younes, Aline Keyrouz, Sergio Mazzola, Yuly P. Mendoza, Grazia Pennisi, Manuel Romero‐Gómez, Antonio Craxı̀, Victor de Lédinghen
Publicado em 2020Artigo -
14
Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease por Rocío Gallego‐Durán, P. Cerro-Salido, Emilio Gómez-González, María Jesús Pareja, Javier Ampuero, María Carmen Rico, R. Aznar, Eduardo Vilar‐Gómez, Elisabetta Bugianesi, Javier Crespo, Francisco José González-Sánchez, R. Aparcero, Inmaculada Moreno, Susana Soto, M. Arias, Javier Abad, Isidora Ranchal, Raúl J. Andrade, José Luís Calleja, Miguel Pastrana, Oreste Lo Iacono, Manuel Romero‐Gómez
Publicado em 2016Artigo -
15
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF) por Mazen Noureddin, Emily Truong, Rebeca Mayo, Ibon Martínez-Arránz, Itziar Mincholé, Jesús M. Bañales, Marco Arrese, Kenneth Cusi, M. Arias, Radan Brůha, Manuel Romero‐Gómez, Paula Iruzubieta, R. Aller, Javier Ampuero, José Luís Calleja, Luis Ibáñez, Patricia Aspichueta, Antonio Martín Duce, Tatyana Kushner, P. Ortiz, Stephen A. Harrison, Quentin M. Anstee, Javier Crespo, José M. Mato, Arun J. Sanyal
Publicado em 2023Artigo -
16
The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity por Javier Ampuero, R. Aller, Rocío Gallego‐Durán, Jesús M. Bañales, Javier Crespo, Carmelo García‐Monzón, María Jesús Pareja, Eduardo Vilar‐Gómez, Juan Caballería, Desamparados Escudero‐García, Judith Gómez‐Camarero, José Luís Calleja, Mercedes Alfaro Latorre, Agustı́n Albillos, Javier Salmerón, Patricia Aspichueta, Oreste Lo Iacono, Rubén Francés, Salvador Benlloch, Conrado Fernández‐Rodríguez, Javier García‐Samaniego, Pamela Estévez, Raúl J. Andrade, Juan Turnés, Manuel Romero‐Gómez
Publicado em 2018Artigo -
17
Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis por Sergio Borgia, Janet Dearden, Eric M. Yoshida, Stephen D. Shafran, Ashley Brown, Ziv Ben‐Ari, Matthew Cramp, Curtis Cooper, Matthew Foxton, Conrado Fernández‐Rodríguez, Rafael Esteban, Robert H. Hyland, Sophia Lu, Brian J. Kirby, Amy Meng, Svetlana Markova, Hadas Dvory‐Sobol, Anu Osinusi, Rafael Bruck, Javier Ampuero, Stephen Ryder, Kosh Agarwal, Raymond Fox, David Shaw, Shariq Haider, Bernard Willems, Yoav Lurie, José Luís Calleja, Edward Gane
Publicado em 2019Artigo -
18
Effectiveness and safety of sofosbuvir‐based regimens plus an <scp>NS</scp>5A inhibitor for patients with <scp>HCV</scp> genotype 3 infection and cirrhosis. Results of a multicente... por Sonia Alonso Sáenz De Oger, Mar Riveiro‐Barciela, Inmaculada Fernández, Diego Rincón, Yolanda Real, Susana Llerena, Francisco Gea, Antonio Olveira, Carlos Fernández‐Carrillo, Benjamín Polo Lorduy, J.A. Carrión, Alexandra Gómez, M. J. Devesa, Carme Baliellas, Á. Castro, Javier Ampuero, Rafael Granados, J.M. Pascasio, Ángel Rubín, Javier Salmerón, E. Badia, J.M. Moreno Planas, Sabela Lens, Juan Turnés, J.L. Montero, Marı́a Buti, Rafael Esteban, Conrado Fernández-Rodrı́guez
Publicado em 2016Artigo -
19
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation por Rocío Gallego‐Durán, Javier Ampuero, Helena Pastor‐Ramírez, Leticia Álvarez‐Amor, José Antonio Del Barrio del Campo, Douglas Maya‐Miles, Rocío Montero‐Vallejo, Antonio Cárdenas-García, M.J. Pareja, Sheila Gato‐Zambrano, Raquel Millán, María del Carmen Rico, Amparo Luque‐Sierra, Antonio Gil‐Gómez, Ángela Rojas, Rocío Múñoz‐Hernández, María del Rosario García-Lozano, R. Aller, Raúl J. Andrade, Carmelo García‐Monzón, Fausto Andreola, Franz Martı́n, Rajiv Jalan, Manuel Romero‐Gómez
Publicado em 2022Artigo -
20
FibroGENE: A gene-based model for staging liver fibrosis por Mohammed Eslam, Ahmed M. Hashem, Manuel Romero‐Gómez, Thomas Berg, Gregory J. Dore, Alessandra Mangia, Henry Lik‐Yuen Chan, William L. Irving, David Sheridan, Maria Lorena Abate, Leon A. Adams, Martin Weltman, Elisabetta Bugianesi, Ulrich Spengler, Olfat Shaker, Janett Fischer, Lindsay Mollison, Wendy Cheng, Jacob Nattermann, Stephen M. Riordan, Luca Miele, Kebitsaone Simon Kelaeng, Javier Ampuero, Golo Ahlenstiel, Duncan McLeod, Elizabeth E. Powell, Christopher Liddle, Mark W. Douglas, David R. Booth, Jacob George
Publicado em 2015Artigo
Ferramentas de busca:
Assuntos relacionados
Medicine
Internal medicine
Gastroenterology
Disease
Fatty liver
Cirrhosis
Fibrosis
Liver disease
Endocrinology
Immunology
Steatohepatitis
Biochemistry
Biology
Liver fibrosis
Biopsy
Chemistry
Cohort
Liver biopsy
Nonalcoholic fatty liver disease
Pathology
Transient elastography
Virus
Hepatitis C
Hepatitis C virus
Hepatocellular carcinoma
Inflammation
Chronic liver disease
Diabetes mellitus
Gene
Hepatic encephalopathy